Every SEC Form 3/4/5 on record for this filer (CIK 1798443) — 1 issuer, 33 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, Chief Financial Officer | 2020-01-02 → 2026-06-16 | 31 | −$25M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| TEVA | 2026-06-11 | Sell | 106,563 | $34.10 | $4M | 65,621 |
| TEVA | 2026-05-14 | Sell | 153,251 | $35.61 | $5M | 172,184 |
| TEVA | 2026-02-26 | Sell | 345,810 | $33.64 | $12M | 57,478 |
| TEVA | 2025-06-12 | Sell | 55,775 | $17.08 | $952,637 | 403,288 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.